Topas Therapeutics

Business Services · Germany · 11-50 Employees

View Company Info for Free

Overview

Headquarters

Falkenried 88, Hamburg, Hamburg, 20251, ...

Phone Number

+49 40302089010

Revenue

$6 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Topas Therapeutics

Topas Therapeutics is pioneering a novel approach to establish immune tolerance in autoimmune and immune-mediated diseases through its proprietary antigen-specific nanoparticle technology. The company's lead candidate, TPM502, has shown promising results in a Phase 2a clinical trial for celiac disease and is preparing for a global Phase 2b trial. Their Topas Particle Conjugates target liver sinusoidal endothelial cells to induce anti-inflammatory immune responses and promote T cell tolerance. By addressing the underlying mechanisms of autoimmune diseases, Topas aims to provide significant therapeutic benefits to patients with limited treatment options.Explore more
Topas Therapeutics's Social MediaPopular SearchesTopas Therapeutics GmbHTopas TherapeuticsSIC Code 87,873NAICS Code 54,541Show more

Is Topas Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Topas Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Topas Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Topas Therapeutics.

Topas Therapeutics financials insights

Gather financial insights about Topas Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2016

Series A

$16.5M

2020

Series B

$26M

See All Topas Therapeutics's Financials Insights

Topas Therapeutics Tech Stack

A closer look at the technologies used by Topas Therapeutics

Most Recent Scoops

New Hire
Executive Move
Executive Moves, New Hire
Promotion
Executive Move
New Hire
Executive Move
Funding
Left Company
Executive Move
See more scoops

Top Business Services Companies

Frequently Asked Questions Regarding Topas Therapeutics

What is Topas Therapeutics's official website?
Topas Therapeutics's official website is www.topas-therapeutics.com
What is Topas Therapeutics's Revenue?
Topas Therapeutics's revenue is $6 Million
What is Topas Therapeutics's SIC code?
Topas Therapeutics's SIC: 87,873
What is Topas Therapeutics's NAICS code?
Topas Therapeutics's NAICS: 54,541
How many employees does Topas Therapeutics have?
Topas Therapeutics has 11-50 employees
What industry does Topas Therapeutics belong to?
Topas Therapeutics is in the industry of: Business Services, Research & Development
What technology does Topas Therapeutics use?
Some of the popular technologies that Topas Therapeutics uses are: WordPress.org, PHP, jQuery Migrate, UIkit
How do I contact Topas Therapeutics?
Topas Therapeutics contact info: Phone number: +49 40302089010 Website: www.topas-therapeutics.com
What does Topas Therapeutics do?

Topas Therapeutics is pioneering a novel approach to establish immune tolerance in autoimmune and immune-mediated diseases through its proprietary antigen-specific nanoparticle technology. The company's lead candidate, TPM502, has shown promising results in a Phase 2a clinical trial for celiac disease and is preparing for a global Phase 2b trial. T... heir Topas Particle Conjugates target liver sinusoidal endothelial cells to induce anti-inflammatory immune responses and promote T cell tolerance. By addressing the underlying mechanisms of autoimmune diseases, Topas aims to provide significant therapeutic benefits to patients with limited treatment options.Read More

What are Topas Therapeutics social media links?
Topas Therapeutics Linkedin page
Who invested in Topas Therapeutics?
Topas Therapeutics has 6 investors including Gimv, Epidarex Capital, EMBL Ventures and Evotec.
Is Topas Therapeutics a public company?
Topas Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Topas Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.